Results 1 to 10 of about 718,081 (348)
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
New England Journal of Medicine, 2021 Summary We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19).
N. H. Schultz +10 more
semanticscholar +1 more source
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
New England Journal of Medicine, 2021 Background Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a new syndrome associated with the ChAdOx1 nCoV-19 adenoviral vector vaccine against severe acute respiratory syndrome coronavirus 2. Data are lacking on the clinical features of
S. Pavord +8 more
semanticscholar +1 more source
British medical journal, 2022 Objective To quantify the risk of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19. Design Self-controlled case series and matched cohort study. Setting National registries in Sweden. Participants 1 057 174 people who tested positive
I. Katsoularis +7 more
semanticscholar +1 more source
Interplay between inflammation and thrombosis in cardiovascular pathology
Nature Reviews Cardiology, 2021 Thrombosis is the most feared complication of cardiovascular diseases and a main cause of death worldwide, making it a major health-care challenge. Platelets and the coagulation cascade are effectively targeted by antithrombotic approaches, which carry ...
K. Stark, S. Massberg
semanticscholar +1 more source
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
New England Journal of Medicine, 2020 BACKGROUND Progressive respiratory failure is the primary cause of death in the coronavirus disease 2019 (Covid-19) pandemic. Despite widespread interest in the pathophysiology of the disease, relatively little is known about the associated morphologic ...
M. Ackermann +13 more
semanticscholar +1 more source
COVID-19 and its implications for thrombosis and anticoagulation
Blood, 2020 Severe acute respiratory syndrome coronavirus 2, coronavirus disease 2019 (COVID-19)-induced infection can be associated with a coagulopathy, findings consistent with infection-induced inflammatory changes as observed in patients with disseminated ...
J. Connors, J. Levy
semanticscholar +1 more source
The Journal of Haemophilia Practice, 2023 Haemophilia A and B are X-linked inherited bleeding disorders, resulting in the deficiency of clotting factor VIII and IX, respectively. Since the introduction of recombinant clotting factor concentrates in the early 1990s, the major safety concern for ...
Buckner Tyler W. +5 more
doaj +1 more source
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System.
Journal of the American Medical Association (JAMA), 2020 This study examines the incidence of and risk factors for venous and arterial thrombosis in patients hospitalized with COVID-19 in 4 New York City hospitals.
S. Bilaloglu +5 more
semanticscholar +1 more source
Thrombosis Journal, 2023 Background In patients with hemophilia (PwH), bleeding often occurs in joints and muscles, and early detection of hemorrhage is important to prevent the onset and progression of mobility impairment.
Ryohei Kawasaki +10 more
doaj +1 more source
Bleeding, Thrombosis and Vascular Biology, 2022 Vaccination with ChAdOx1 nCoV-19 can result in vaccine-induced immune thrombotic thrombocytopenia (VITT). This phenomenon mimics heparin-induced thrombocytopenia, yet it does not require heparin as a trigger.
Rita Carlotta Santoro +8 more
doaj +1 more source